The Government clarified that despite rupee depreciation, strong forex reserves and export competitiveness offset risks. The ...

Maximize Market Research's Industrial Gearbox Market Global Outlook (2025-2032) provides a comprehensive assessment of revenue, growth ...

Neumora Therapeutics is downgraded from 'Strong Buy' to 'Hold' following KOASTAL-1's failure in the MDD primary endpoint.

Absci Corporation downgraded to Hold as ABS-101 stalls and focus shifts to ABS-201; cash runway to H1 2028, but risks persist ...

Objective To evaluate the impact of an Australian Virtual Care service on low-acuity patient presentations to emergency departments (EDs) across a local health district. Design This was a ...

Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical-stage biopharmaceutical company developing innovative products focused on the treatment or prevention of gastrointestinal cancers, announces its ...

It’s one thing to deliberately misrepresent a group’s opinion about a project and another to use that opinion to help sway a vote. Yet that’s what Supervisor Kathy Smith (D-Sully) did last week prior ...

Claranova (Euronext Growth : FR0013426004 - ALCLA) improved its operating margin and reported positive net income while maintaining debt under control in H1 2025-2026 (July to December 2025), in line ...

Share Market Highlights - Find here all the highlights related to Sensex, Nifty, BSE, NSE, share prices and Indian stock ...

ORLANDO, Fla., March 30, 2026 /PRNewswire/ -- accesso Technology Group (AIM: ACSO), the leading global technology provider to leisure, entertainment and cultural markets, today announced the ...

Tribunal ruled that share transactions cannot be treated as loans without proof of exceptional circumstances. Notional interest addition on such re-characterisation was ...

Biodexa Pharmaceuticals PLC Stephen Stamp, CEO Fiona Sharp, CFO Tel: +44 (0)29 2048 0180 The Company's lead development programs include eRapa, under development for Familial Adenomatous Polyposis and ...